Adtralza 150 mg solution for injection in pre-filled syringe, The placebo presentation is a pre-filled syringe containing the same excipients in the same amounts as the IMP.
LP0162-1336
Phase 3 small_molecule active
Quick answer
Adtralza 150 mg solution for injection in pre-filled syringe, The placebo presentation is a pre-filled syringe containing the same excipients in the same amounts as the IMP. for Treatment of moderate-to-severe Atopic dermatitis is a Phase 3 program (small_molecule) at LEO Pharma A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- LEO Pharma A/S
- Indication
- Treatment of moderate-to-severe Atopic dermatitis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active